Myria Biosciences

Private

BaselHealthcare & Life Scienceshttps://www.myria.bio/

Last Round

Pre Seed

Jun 20, 2024

Company Overview

Myria Biosciences is a biotechnology company that develops therapeutic molecules using its synthetic intelligence platform to transform drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discovery platformAI drug discoverysynthetic biologytech-biogenerative biologynatural product discoveryundruggable targetsAI-native biotechdrug discovery engineGEMMS platformhigh-throughput screeningSynBiobiopharmaceuticalsdrug candidate pipelinepharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myria Biosciences Comps

Public and private peers based on sector, stage, and business model.

Myria Biosciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Myria Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Jun 20, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Steven Schmitt

CEO, Cofounder

Founding Team

Myria Biosciences Investors

Notable investors and investment history

Myria Biosciences investors
Investor	Rounds
Capital Blue Partners	Pre Seed
Rockmount Seed Investments	Pre Seed
The Creator Fund	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 5, 2026
Monthly visitors increased 46% MoM.
Jul 2, 2025
Monthly visitors increased 553% MoM.

View all signals

Myria Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Myria Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myria Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel

Employee Range9

Year Founded2022

Last FundingJun 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.